Fred Larimore, Ph.D. has been named vice president of scientific affairs and chief scientific officer for
Cook Pharmica, the global contract biopharmaceutical manufacturing division of Cook Medical.
Dr. Larimore has more than 25 years of biotech experience beginning at Eli Lilly with the development and manufacturing of recombinant human insulin. His career at Eli Lilly included integral work for recombinant human growth hormone, recombinant human parathyroid hormone, bovine somatotropin, and several research monoclonal antibodies and antibody conjugates. Additionally, he led multiple initiatives in process aspects of facility design, scale-up and start-up. He was responsible for the redevelopment of the recombinant human insulin and recombinant human growth hormone processes and provided technical leadership and oversight for the company’s protein product portfolio.
“Fred has provided critical leadership for the development group for the last two years and has been extremely effective in building a strong team,” said Cook Pharmica president Jerry Arthur. “His extensive industry experience, scientific expertise, and strong leadership qualities have been foundational to the success of our company and will continue to be as we expand.”
Magazine
